This is analogous to the evidence pathway followed for liraglutide (LEADER trial, NEJM 2016) and semaglutide (SUSTAIN-6 trial, NEJM 2016), which established cardiovascular benefit for those agents only after large, long-term CVOTs reported [6] The heart rate increase warrants ongoing surveillance, particularly in patients with pre-existing cardiac conditions Phase 3 trials are currently underway (see ClinicalTrials.gov and the EU Clinical Trials Information System, CTIS, for registered studies)
We make the process clear, supportive, and centered on you
He has written well over a thousand articles for the general public on a wide range topics, including health, astronom
Endoscopic therapies, including intragastric balloon therapy and endoscopic sleeve gastroplasty, generally produce more modest weight loss, often approximately 10%-13% at 6 months depending on procedure, patient selection, and follow-up intensity
Singh N, Stewart RAH, Benatar JR